Minnesota Oncology Hematology PA is a clinical research site located in Edina, Minnesota, United States 55435.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
Minnesota Oncology Hematology PA has participated in 9 clinical trials with 6 currently active.
Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: Pfizer, Novartis Pharmaceuticals, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Minnesota · View every site in Edina
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Minnesota Oncology Hematology PA has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Minnesota Oncology Hematology PA has 9 clinical trials on record, with 6 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Ovarian Cancer, Fallopian Tube Cancer.
Minnesota Oncology Hematology PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.